Rising Numbers Of Surgeries Drives Growth Of Small-Volume Parenteral Market: Core Growth Enabler in the Small Volume Parenteral Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Small Volume Parenteral Industry Market Size Be by 2025?
In recent years, there has been significant growth in the small volume parenteral market size. It is projected to expand from $177.26 billion in 2024 to $193.16 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to the growth during the historic period include the increasing incidence of chronic illnesses, regulatory authorizations and government initiatives, trends in outsourcing pharmaceutical services, as well as the globalization and growth of the pharmaceutical markets.

What's the Long-Term Growth Forecast for the Small Volume Parenteral Market Size Through 2029?
In the upcoming years, the size of the small volume parenteral market is projected to witness substantial growth. With a compound annual growth rate (CAGR) of 8.6%, it is predicted to reach $268.53 billion by 2029. The anticipated growth during the forecast period is due to factors such as the growth of the biologics market, improvements in healthcare infrastructure, higher rates of hospitalization, various regulatory approvals, a move towards home healthcare, increased healthcare investments, and worldwide health crises. Key trends predicted in this forecasting period consist of developments in biocompatible formulations, patient-oriented strategies, the expansion of home healthcare, advancements in automated manufacturing, broadening of therapeutic areas, and the rise of smart pump technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

What Are the Key Growth Drivers Fueling the Small Volume Parenteral Market Expansion?
The growth of the small-volume parenteral market is anticipated to be fueled by the surge in surgical procedures. Surgery, a medical domain using operative methods for the exploration or treatment of pathological conditions including disease or injury, enhancing bodily functionality or looks, or mending undesirable broken areas, is on the rise. This increase can be attributed to medical technology advancements and an older population, escalating the need for surgical interventions. Small-volume parenteral solutions, integral in surgical procedures, allow precise administration of medicines, electrolytes, and nutrients straight into the bloodstream. As an example, The Aesthetic Society, a US-based association for plastic surgery and cosmetic medicine, reported in August 2023 that over $11.8 billion was spent by Americans on aesthetic procedures, marking a 2% increase from the prior year. Consequently, the escalating number of surgeries is propelling the expansion of the small-volume parenteral market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp

What Are the Key Trends Driving Small Volume Parenteral Market Growth?
Prominent entities in the small volume parenteral market are concentrating their efforts on devising novel solutions such as an integrated lyophilizer to bolster their market earnings. The integrated lyophilizer is a sophisticated system incorporated into the production line to freeze and dry products, yielding lyophilized powders mostly employed in particular parenteral drugs. For example, WuXi STA, a pharmaceutical firm based in China, unveiled a parenteral formulation manufacturing line in January 2022. This fresh production line, along with the aseptic manufacturing facility sited in Wuxi, has been configured to abide by the cGMP requirements instituted by the U.S. FDA, EMA, and China NMPA. It is equipped with the most advanced isolation systems and filling apparatus in the sector. The entire filling operation is executed by robotics within a completely isolated setup, purposely built to minimize human interference and avert contamination, thus securing superior product quality.

How Is the Small Volume Parenteral Market Segmented?
The small volume parenteral market covered in this report is segmented -

1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users

Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15925&type=smp

Which Companies Are Leading the Charge in Small Volume Parenteral Market Innovation?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc., Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

Which Regions Are Leading the Global Small Volume Parenteral Market in Revenue?
North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15925

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.